BioCentury | Jul 20, 2015
Company News

NeuroVive, Sanofi deal

...NeuroVive’s NeuroVive Pharmaceutical Asia Inc. subsidiary granted Sanofi rights to commercialize CicloMulsion in South Korea. NeuroVive Asia will receive an...
...is in the European Phase III CIRCUS trial to treat reperfusion injury following myocardial infarct. NeuroVive Asia...
BioCentury | Feb 16, 2015
Financial News

NeuroVive Asia completes venture financing

...Pacific; NeuroVive Pharmaceutical AB ; and other investors Note: NeuroVive Pharmaceutical AB (Lund, Sweden) established NeuroVive Pharmaceutical Asia Inc....
BioCentury | Feb 13, 2015
Company News

Sweden's NeuroVive prepares for Taiwan IPO

...Swedish neurology company NeuroVive Pharmaceutical AB (SSE:NVP) established a Taiwan subsidiary, NeuroVive Pharmaceutical Asia Inc. (NeuroVive Asia), with $3.3 million...
...its Asian divisions so that its offices in Taiwan and Hong Kong report to NeuroVive Asia. NeuroVive Asia...
Items per page:
1 - 3 of 3
BioCentury | Jul 20, 2015
Company News

NeuroVive, Sanofi deal

...NeuroVive’s NeuroVive Pharmaceutical Asia Inc. subsidiary granted Sanofi rights to commercialize CicloMulsion in South Korea. NeuroVive Asia will receive an...
...is in the European Phase III CIRCUS trial to treat reperfusion injury following myocardial infarct. NeuroVive Asia...
BioCentury | Feb 16, 2015
Financial News

NeuroVive Asia completes venture financing

...Pacific; NeuroVive Pharmaceutical AB ; and other investors Note: NeuroVive Pharmaceutical AB (Lund, Sweden) established NeuroVive Pharmaceutical Asia Inc....
BioCentury | Feb 13, 2015
Company News

Sweden's NeuroVive prepares for Taiwan IPO

...Swedish neurology company NeuroVive Pharmaceutical AB (SSE:NVP) established a Taiwan subsidiary, NeuroVive Pharmaceutical Asia Inc. (NeuroVive Asia), with $3.3 million...
...its Asian divisions so that its offices in Taiwan and Hong Kong report to NeuroVive Asia. NeuroVive Asia...
Items per page:
1 - 3 of 3